MAGE-A1 expression is associated with good prognosis in neuroblastoma tumors

Journal of Cancer Research and Clinical Oncology

Volumn 135, Issue 4, 2009, Pages 523-531

  Grau, Elena ^a   Oltra, Silvestre ^a   Martínez, Francisco ^a   Orellana, Carmen ^a   Cañete, Adela ^a   Fernández, Jose María ^a   Hernández Martí, Miguel ^a   Castel, Victoria ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Cancer testis antigens; Hypomethylation; MAGE A1; Neuroblastoma; Prognosis factor

Indexed keywords

COMPLEMENTARY DNA; MELANOMA ANTIGEN 1; MELANOMA ANTIGEN 3;

ARTICLE; BONE MARROW CELL; CANCER STAGING; CANCER SURVIVAL; CELL INFILTRATION; CHILD; CLINICAL ARTICLE; DISEASE ASSOCIATION; EPIGENETICS; FEMALE; GENE AMPLIFICATION; GENE FUNCTION; GENE SEQUENCE; GENE SILENCING; HUMAN; INFANT; MALE; METHYLATION; MICROSATELLITE INSTABILITY; NEUROBLASTOMA; ONCOGENE C MYB; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION;

ANTIGENS, NEOPLASM; DISEASE-FREE SURVIVAL; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASES; HUMANS; NEOPLASM PROTEINS; NEOPLASM STAGING; NEUROBLASTOMA; PROGNOSIS; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; SURVIVAL ANALYSIS; SURVIVORS;

EID: 61449202898     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-008-0484-1     Document Type: Article

References (28)

1. M Alonso R Hamelin M Kim K Porwancher T Sung P Parhar 2001 Microsatellite instability occurs in distinct subtypes of pediatric but not adult central nervous system tumors Cancer Res 61 2124 2128
2. EF Attiyeh WB London YP Mosse Q Wang C Winter D Khazi Children's Oncology Group 2005 Chromosome 1p and 11q deletions and outcome in neuroblastoma N Engl J Med 353 21 2215 2217 10.1056/NEJMoa052399
3. N Bown 2001 Neuroblastoma tumor genetics: Clinical and biological aspects J Clin Pathol 54 897 910
4. GM Brodeur RC Seeger A Barrett F Berthold RP Castleberry G D'Angio 1988 International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma J Clin Oncol 6 1874 1881
5. IY Cheung NK Cheung 2001 Detection of microscopic disease: comparing histology, immunocytology, and RT-PCR of tyrosine hydroxylase, GAGE, and MAGE Med Pediatr Oncol 36 210 212 10.1002/1096-911X(20010101)36:1<210::AID- MPO1051>3.0.CO;2-F
6. B Cho H Lee S Jeong YJ Bang HJ Lee KS Hwang 2003 Promoter hypomethylation of a novel cancer/testis antigen gene CAGE is correlated with its aberrant expression and is seen in premalignant stage of gastric carcinoma Biochem Biophys Res Commun 307 52 63 10.1016/S0006-291X(03)01121-5
7. E De Plaen K Arden C Traversari JJ Gaforio JP Szikora C De Smet 1994 Structure, chromosomal localization and expression of twelve genes of the MAGE family Inmunogenetics 40 360 369 10.1007/BF01246677
8. C De Smet O De Backer I Faraoni C Lurquin F Brasseur T Boon 1996 The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation Proc Natl Acad Sci USA 93 7149 7153 10.1073/pnas.93.14.7149
9. C De Smet C Lurquin B Lethe V Martelange T Boon 1999 DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter Mol Cell Biol 19 7327 7335
10. C De Smet A Loriot T Boon 2004 Promoter-dependent mechanism leading to selective hypomethylation within the 5 region of gene MAGE-A1 in tumor cells Mol Cell Biol 24 4781 4790 10.1128/MCB.24.11.4781-4790.2004
11. E Grau S Oltra C Orellana M Hernández-Martí V Castel F Martínez 2005 There is no evidence that the SDHB gene is involved in neuroblastoma development Oncol Res 15 7-8 393 398
12. JG Herman JR Graff S Myohanen BD Nelkin SB Baylin 1996 Methylation specific PCR: a novel PCR assay for methylation status of CpG islands Proc Natl Acad Sci USA 93 9821 9826 10.1073/pnas.93.18.9821
13. JF Jacobs F Brasseur CA Hulsbergen-van de Kaa MW van de Rakt CG Figdor GJ Adema 2007 Cancer-germline gene expression in pediatric solid tumors using quantitative real-time PCR Int J Cancer 120 1 67 74 10.1002/ijc.22118
14. SJ James IP Pogribny M Pogribna BJ Miller S Jernigan S Melnyk 2003 Mechanisms of DNA damage, DNA hypomethylation, and tumor progression in the folate/methyl-deficient rat model of hepatocarcinogenesis J Nutr 133 11 Suppl 1 3740S 3747S
15. M Jurk E Kremmer U Schwarz R Forster EL Winnacker 1998 MAGE-11 protein is highly conserved in higher organisms and located predominantly in the nucleus Int J Cancer 75 762 766 10.1002/(SICI)1097-0215(19980302)75:5<762::AID- IJC16>3.0.CO;2-8
16. S Laduron R Deplus S Zhou O Kholmanskikh D Godelaine C De Smet 2004 MAGE-A1 interacts with adaptor SKIP and the deacetylases HDAC1 to repress transcription Nucleic Acids Res 14 4340 4350 10.1093/nar/gkh735
17. JM Maris KK Matthay 1999 Molecular biology of neuroblastoma J Clin Oncol 7 7 2264 2279
18. R Noguera A Canete A Pellin A Ruiz M Tasso S Navarro 2003 MYCN gain and MYCN amplification in a stage 4S neuroblastoma Cancer Genet Cytogenet 140 2 157 161 10.1016/S0165-4608(02)00677-5
19. S Oltra F Martinez C Orellana E Grau JM Fernandez A Cañete 2004 Minimal residual disease in neuroblastoma: to GAGE or not to GAGE Oncol Res 14 6 291 295
20. S Raptis B Bapat 2006 Genetic instability in human tumors EXS 96 303 320
21. D Rimoldi S Salvi D Reed P Coulie VC Jongeneel E De Plaen 1999 cDNA and protein characterization of human MAGE-10 Int J Cancer 82 901 907 10.1002/(SICI)1097-0215(19990909)82:6<901::AID-IJC21>3.0.CO;2-X
22. D Rodenhiser M Mann 2006 Epigenetics and human disease: translating basic biology into clinical applications CMAJ 174 341 348 10.1503/cmaj.050774
23. UC Rogner K Wilke E Steck B Korn A Poustka 1995 The melanoma antigen gene (MAGE) family is clustered in the chromosomal band Xq28 Genomics 29 725 731 10.1006/geno.1995.9945
24. S Ropero MF Fraga E Ballestar R Hamelin H Yamamoto M Boix-Chornet 2006 A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition Nat Genet 38 566 569 10.1038/ng1773
25. E Schultz-Thater A Juretic P Dellabona U Lüscher W Siegrist F Harder 1994 MAGE-1 gene product is a cytoplasmic protein Int J Cancer 59 435 439 10.1002/ijc.2910590324
26. A Soling P Schurr F Berthold 1999 Expression and clinical relevance of NY-ESO-1, MAGE-1 and MAGE-3 in neuroblastoma Anticancer Res 19 2205 2209
27. M Wolfl AA Jungbluth F Garrido T Cabrera S Meyen-Southard R Spitz 2005 Expression of MHC class I, MHC class II, and cancer germline antigens in neuroblastoma Cancer Immunol Immunother 54 400 406 10.1007/s00262-004-0603-z
28. J Zhang J Yu J Gu BM Gao YJ Zhao P Wang 2004 A novel protein-DNA interaction involved with the CpG dinucleotide at -30 upstream is linked to the DNA methylation mediated transcription silencing of the MAGE-A1 gene Cell Res 14 4 283 294 10.1038/sj.cr.7290229